Definition/General
Introduction:
Barrett esophagus is a premalignant condition characterized by replacement of normal squamous epithelium with columnar epithelium containing goblet cells
It is associated with gastroesophageal reflux disease
Cytological surveillance is important for early cancer detection.
Origin:
Barrett esophagus develops due to chronic acid reflux
Metaplastic transformation of squamous to columnar epithelium
Intestinal metaplasia with goblet cells required for diagnosis
Regenerative response to chronic injury.
Classification:
Classified by length of involvement
Long-segment Barrett (≥3 cm)
Short-segment Barrett (<3 cm)
Ultra-short segment (<1 cm)
Graded by dysplasia degree
Non-dysplastic
Low-grade dysplasia
High-grade dysplasia.
Epidemiology:
Prevalence 1-2% in general population
Male predominance (3:1)
White population more affected
Associated with GERD
Risk increases with age
Annual cancer risk 0.1-0.3%.
Clinical Features
Presentation:
Chronic heartburn
Acid regurgitation
Dysphagia
Chest pain
Nocturnal symptoms
Often asymptomatic
Incidental finding.
Symptoms:
Persistent GERD symptoms
Burning chest pain
Difficulty swallowing
Regurgitation of food
Chronic cough
Hoarse voice.
Risk Factors:
Chronic GERD (>5 years)
Male gender
Age >50 years
White race
Obesity
Smoking
Family history.
Screening:
Endoscopic surveillance
High-risk patient screening
Chromoendoscopy
Advanced imaging techniques
Biomarker development.
Master Barrett Esophagus Pathology with RxDx
Access 100+ pathology videos and expert guidance with the RxDx app
Gross Description
Appearance:
Salmon-pink mucosa
Tongues or circumferential involvement
Irregular Z-line
Velvet-like appearance
Nodular areas (dysplasia)
Ulceration (high-grade).
Characteristics:
Smooth, glistening surface
Color contrast with normal squamous mucosa
Irregular margins
Variable extent
Islands of squamous mucosa.
Size Location:
Length: Short segment <3 cm
Long segment ≥3 cm
Distal esophagus involvement
Gastroesophageal junction
Prague classification for mapping.
Multifocality:
Circumferential or tongues
Skip areas common
Mosaic pattern
Islands of normal mucosa
Progressive extent possible.
Microscopic Description
Histological Features:
Columnar epithelium with goblet cells
Intestinal metaplasia
Mucin-containing goblet cells
Surface foveolar cells
Crypts resembling intestinal architecture
Basement membrane intact.
Cellular Characteristics:
Columnar cells with basal nuclei
Goblet cells with apical mucin
Paneth cells occasionally present
Endocrine cells
Uniform nuclear features (non-dysplastic)
Mucin types (neutral and acidic).
Architectural Patterns:
Villiform surface
Crypts extending into lamina propria
Intestinal-type architecture
Goblet cell distribution
Surface epithelium continuity.
Grading Criteria:
Non-dysplastic: Regular architecture, uniform nuclei
Low-grade dysplasia: Architectural distortion, mild atypia
High-grade dysplasia: Severe architectural distortion, marked atypia
Intramucosal carcinoma.
Immunohistochemistry
Positive Markers:
CK7 (surface epithelium)
CK20 (goblet cells)
CDX2 (intestinal differentiation)
MUC2 (goblet cells)
Villin
TFF3 (trefoil factor).
Negative Markers:
CK5/6 (squamous markers)
p63 (squamous marker)
MUC5AC (gastric marker, variable)
MUC6 (gastric marker).
Diagnostic Utility:
Confirms intestinal metaplasia
Goblet cell identification
Differentiation from gastric metaplasia
Dysplasia grading
Surveillance monitoring.
Molecular Subtypes:
Intestinal phenotype (CK20+, CDX2+, MUC2+)
Gastric phenotype (rare)
Mixed phenotype
Dysplasia-associated changes.
Molecular/Genetic
Genetic Mutations:
TP53 mutations (high-grade dysplasia)
CDKN2A deletions
APC mutations
PIK3CA mutations
SMAD4 mutations
Chromosomal instability.
Molecular Markers:
p53 expression (dysplasia)
Cyclin D1
EGFR expression
Ki-67 proliferation index
DNA ploidy
Telomerase activity.
Prognostic Significance:
Length of Barrett segment
Presence of dysplasia
p53 alterations
Aneuploidy
Molecular progression markers.
Therapeutic Targets:
Proton pump inhibitors
Antireflux surgery
Radiofrequency ablation
Endoscopic mucosal resection
Photodynamic therapy.
Differential Diagnosis
Similar Entities:
Gastric-type metaplasia
Inflammatory changes
Reactive epithelium
Adenocarcinoma
Dysplasia.
Distinguishing Features:
Barrett: Goblet cells present
Barrett: Intestinal markers positive
Gastric metaplasia: No goblet cells
Inflammatory: Mixed cell population
Carcinoma: Invasive growth.
Diagnostic Challenges:
Goblet cell identification
Sampling adequacy
Dysplasia grading
Reactive vs neoplastic changes
Short segment Barrett.
Rare Variants:
Multilayered epithelium
Pancreatic metaplasia
Ciliated epithelium
Oxyntocardiac mucosa.
Sample Pathology Report
Template Format
Sample Pathology Report
Complete Report: This is an example of how the final pathology report should be structured for this condition.
Specimen Information
Esophageal cytology, [technique used], adequate for evaluation
Diagnosis
Barrett esophagus with [dysplasia grade]
Columnar Metaplasia
Columnar epithelium showing [intestinal metaplasia] with [goblet cells]
Goblet Cells
Goblet cells: [present/absent], [distribution pattern]
Dysplasia Assessment
Dysplasia: [negative/low-grade/high-grade/indefinite]
Nuclear Features
Nuclear features: [regular/mildly atypical/markedly atypical]
Architectural Features
Architecture: [preserved/mildly distorted/markedly distorted]
Clinical Correlation
Clinical correlation with [endoscopic findings] and [GERD history]
Final Diagnosis
Esophageal cytology: Barrett esophagus